Quality of life of patients during antineoplastic therapy: a descriptive study

Aim:  To  evaluate  the  quality  of  life  of  cancer  patients  using the device  for  antineoplastic  continuous  infusion.  Method:  This  is  a  cross-sectional  study conducted  with  28  patients in  a  health  insurance  company  of Fortaleza/CE in  2013,  by applying  the  life  quality  assessment  tool  of  the  World  Health  Organization  (WHOQOL-BREF). Results: The domain most affected was health satisfaction, which was negative in both  antineoplastic  administration  cycles,  while  the  perception  regarding  quality  of  life was  considered  regular.  The  highest  average  domain  was  social  relations;  the  lowest average  was  the  psychological  domain  for  both  cycles.  Conclusion:  It  is  important  to know the determinants that influence the quality of life of cancer patients, allowing the improvement of multidisciplinary interventions to increase adaptation to the experience of the disease.